Transkutanöz Radyofrekans Tedavisinin Miyofasyal Ağrı Sendromlu Hastalar Üzerindeki Terapötik Etkisinin Değerlendirilmesi: Klinik Çalışma

Öz

Amaç: Bu çalışma, miyofasyal ağrı sendromu tanısı alan hastalarda, transkutanöz radyofrekans tedavisinin kronik ağrı üzerindeki etkisini araştırmıştı. Hastalar ve Yöntemler: Ocak-Ağustos 2021 tarihleri arasında Ordu Devlet Hastanesi Ağrı Polikliniği'ne başvuran 30 hastanın verileri üzerinde retrospektif analiz yapıldı. Bu hastalarda üst trapezius kas bölgesinde miyofasyal ağrı ile uyumlu tetik noktalar sergiliyordu. Hasta grubunun 22'si kadın (%73,3) ve 8'i erkek (%26,7) olup yaş ortalaması 45,27±13,05 idi. İşlem öncesi bazal Görsel Analog Skala skorları kaydedildi ve işlem sonrası 1., 4. ve 12. haftalarda VAS ölçümleri yapıldı. Toplam analjezik kullanımı ve Hastanın Global Değişim İzlenimi skorları da 1. haftadan itibaren değerlendirildi. Bulgular: Miyofasiyal ağrı sendromu tanısı alan hastalarda, VAS skorlarında ve TAU'da 1. haftadan itibaren anlamlı bir azalma gözlendi ve 4. haftaya kadar devam etti. PGIC puanlarının analizi, hastaların 1. haftada %77'lik bir memnuniyet seviyesi bildirdiğini, 2. haftada memnuniyette istatistiksel olarak anlamlı olmasa da hafif bir artış olduğunu ve ardından dördüncü haftadan itibaren memnuniyette bir düşüş olduğunu ortaya çıkardı. Sonuç: Transkutanöz radyofrekans tedavisinin, analjezik tüketimini azaltmada ve miyofasyal ağrıyı hafifleterek yaşam kalitesini artırmada etkinliği gösterilmiştir. Bu invaziv olmayan, ağrısız ve kolayca uygulanan tedavi yöntemi, miyofasyal ağrı sendromunun ötesinde çeşitli ağrı durumlarının ele alınması için umut vaat ettiği söylenebilirdi.

Anahtar Kelimeler

• Miyofasiyal ağrı sendromu
• transkutanöz radyofrekans terapisi
• yaşam kalitesi

Evaluating the Therapeutic Impact of Transcutaneous Radiofrequency Therapy on Myofascial Pain Syndrome Patients: A Clinical Study

Öz

Abstract Objective: This study investigated the impact of transcutaneous radiofrequency therapy on chronic pain among patients diagnosed with myofascial pain syndrome. Patients and Methods: A retrospective analysis was conducted on data from 30 patients who sought treatment at the pain outpatient clinic of Ordu State Hospital between January and August 2021. These patients exhibited trigger points consistent with myofascial pain in the upper trapezius muscle region. The patient cohort comprised 22 females (73.3%) and 8 males (26.7%), with a mean age of 45.27±13.05 years. Baseline Visual Analogue Scale scores were recorded before the procedure, and VAS measurements were taken at the 1st, 4th, and 12th weeks post-procedure. Total analgesic use and Patient Global Impression of Change scores were also evaluated starting from the 1st week. Results: Among patients diagnosed with myofascial pain syndrome, a significant reduction in VAS scores and TAU was observed from the 1st week, persisting through the 4th week. Analysis of PGIC scores revealed that patients reported a 77% satisfaction level in the 1st week, with a slight, albeit statistically nonsignificant, increase in satisfaction noted in the 2nd week, followed by a decline in satisfaction from the fourth week onwards. Conclusion: Transcutaneous radiofrequency therapy demonstrates efficacy in reducing analgesic consumption and improving the quality of life by alleviating myofascial pain. This non-invasive, painless, and easily administered treatment modality holds promise for addressing various pain conditions beyond myofascial pain syndrome. Keywords: Myofascial pain syndrome, transcutaneous radiofrequency therapy, quality of life.

Anahtar Kelimeler

• Myofascial pain syndrome
• transcutaneous radiofrequency therapy
• quality of life

Kaynakça

1. 1. Leite FM, Atallah AN, El Dib R, et al. Cyclobenzaprine for the treatment of myofascial pain in adults. Cochrane Database Syst Rev. 2009;(3). doi: 10.1002/14651858.CD006830. pub3
2. 2. Yap EC. Myofascial pain--an overview. Ann Acad Med Singapore. 2007;36(1):43-48.
3. 3. Wheeler AH, Aaron GW. Muscle pain due to injury. Curr Pain Headache Rep. 2001;5(5):441-446. doi:10.1007/s11916- 001-0055-5
4. 4. Desai MJ, Saini V, Saini S. Myofascial pain syndrome: a treatment review. Pain Ther. 2013;2(1):21-36. doi:10.1007/ s40122-013-0006-y
5. 5. Gerwin RD. Diagnosis of myofascial pain syndrome. Phys Med Rehabil Clin N Am. 2014;25(2):341-355. doi: 10.1016/j. pmr.2014.01.011
6. 6. Chua NH, Vissers KC, Sluijter ME. Pulsed radiofrequency treatment in interventional pain management: mechanisms and potential indications-a review. Acta Neurochir (Wien). 2011;153(4):763-771. doi:10.1007/s00701-010-0881-5
7. 7. Chang MC. Efficacy of pulsed radiofrequency stimulation in patients with peripheral neuropathic pain: a narrative review. Pain Physician. 2018;21(3): E225-E234.
8. 8. Van Zundert J, de Louw AJ, Joosten EA, et al. Pulsed and continuous radiofrequency current adjacent to the cervical dorsal root ganglion of the rat induces late cellular activity in the dorsal horn. Anesthesiology. 2005;102(1):125-131. doi:10.1097/00000542-200501000-00021

9. 9. Balogh SE. Transcutaneous application of pulsed radiofrequency: four case reports. Pain Pract. 2004;4(4):310-313. doi:10.1111/j.1533-2500.2004. 04408.x
10. 10. Berger A, Sadosky A, Dukes E, Edelsberg J, Oster G. Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K. Pain Pract. 2009;9(1):18-34. doi:10.1111/j.1533-2500.2008. 00226.x
11. 11. Taverner MG, Ward TL, Loughnan TE. Transcutaneous pulsed radiofrequency treatment in patients with painful knee awaiting total knee joint replacement. Clin J Pain. 2010;26(5):429-432. doi:10.1097/AJP.0b013e- 3181d92a87
12. 12. Taverner M, Loughnan T. Transcutaneous pulsed radiofrequency treatment for patients with shoulder pain booked for surgery: a double-blind, randomized controlled trial. Pain Pract. 2014;14(2):101-108. doi:10.1111/papr.12059
13. 13. Cho IT, Cho YW, Kwak SG, Chang MC. Comparison between ultrasound-guided interfascial pulsed radiofrequency and ultrasound-guided interfascial block with local anesthetic in myofascial pain syndrome of trapezius muscle. Medicine (Baltimore). 2017;96(5). doi:10.1097/ MD.0000000000006019
14. 14. Cao QW, Peng BG, Wang L, et al. Expert consensus on the diagnosis and treatment of myofascial pain syndrome. World J Clin Cases. 2021;9(9):2077-2089. doi:10.12998/ wjcc. v9.i9.2077
15. 15. Lin ML, Chiu HW, Shih ZM, et al. Two transcutaneous stimulation techniques in shoulder pain: transcutaneous pulsed radiofrequency (TPRF) versus transcutaneous electrical nerve stimulation (TENS): a comparative pilot study. Pain Res Manag. 2019; 2019:2823401. doi:10.1155/2019/2823401
16. 16. Niraj G. Pathophysiology and management of abdominal myofascial pain syndrome (AMPS): a three-year prospective audit of a management pathway in 120 patients. Pain Med. 2018;19(11):2256-2266. doi:10.1093/pm/pnx343
17. 17. Park SM, Cho YW, Ahn SH, et al. Comparison of the effects of ultrasound-guided interfascial pulsed radiofrequency and ultrasound-guided interfascial injection on myofascial pain syndrome of the gastrocnemius. Ann Rehabil Med. 2016;40(5):885-892. doi:10.5535/arm.2016.40.5.885
18. 18. Vance CG, Dailey DL, Rakel BA, Sluka KA. Using TENS for pain control: the state of the evidence. Pain Manag. 2014;4(3):197-209. doi:10.2217/pmt.14.13
19. 19. Ahn AC, Colbert AP, Anderson BJ, et al. Electrical properties of acupuncture points and meridians: a systematic review. Bioelectromagnetics. 2008;29(4):245-256. doi:10.1002/ bem.20403
20. 20. Johng HM, Cho JH, Shin HS, et al. Frequency dependence of impedances at the acupuncture point Quze (PC3). IEEE Eng Med Biol Mag. 2002;21(2):33-36. doi:10.1109/ memb.2002.1000183
21. 21. Ahmed S, Haddad C, Subramaniam S, Khattab S, Kumbhare D. The effect of electric stimulation techniques on pain and tenderness at the myofascial trigger point: a systematic review. Pain Med. 2019;20(9):1774-1788. doi:10.1093/pm/pny278
22. 22. Ahmed S, Haddad C, Subramaniam S, Khattab S, Kumbhare D. The effect of electric stimulation techniques on pain and tenderness at the myofascial trigger point: a systematic review. Pain Med. 2019;20(9):1774-1788. Doi:10.1093/ pm/pny278